SWX/SDZ (SWX/SDZ)

SIX Swiss Exchange: SWX/SDZ · CHF

CHF 82.6

-0.26 (-0.3%)· Recorded snapshot

Market cap	35.7B
Revenue (ttm)	9.4B
Net income (ttm)	522M
EPS (ttm)	CHF 1.19
Shares out	432.7M
P/E (trailing)	69.6x
P/E (forward)	22.9x
Dividend	CHF 0.80 (0.97%)
Volume	259,966
Beta	0.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.4B
Net income (ttm): 522M
EPS (ttm): CHF 1.19
P/E (trailing): 69.6x
P/E (forward): 22.9x
Market cap: 35.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E22.9

P25 n/aP50 n/aP75 n/a

Trailing P/E69.6

P25 n/aP50 n/aP75 n/a

ROE7.2

P25 n/aP50 n/aP75 n/a

ROIC6.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/SDZ indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2026-11-06
Employees	20,000
Employees change	-2,356
Employees growth	-10.54%
Enterprise value	CHF 38.9B
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1886
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CH1243598427
Last earnings date	2026-08-05
Last refreshed	2026-11-03
Market cap	CHF 35.7B
Next earnings date	2026-11-06
Price	CHF 82.60
Price currency	CHF
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	swx/SDZ
Website	https://www.sandoz.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	125.07x
Earnings yield	1.44%
EV/Earnings	74.78x
EV/EBIT	44.65x
EV/EBITDA	29.28x
EV/FCF	34.85x
EV/Sales	4.14x
FCF / EV yield	2.87%
FCF yield	3.12%
Forward P/E	22.89x
Graham number	21.12864
Graham upside	-74.5%
Industry P/E	60.61x
Lynch fair value	CHF 5.93
Lynch upside	-92.84%
P/(FCF - SBC) ratio	36.25x
P/(OCF - SBC) ratio	24.93x
P/B ratio	4.93x
P/E ratio	69.61x
P/FCF ratio	32.01x
P/OCF ratio	22.85x
P/S ratio	3.8x
PEG ratio	1.91x
Price/EBITDA ratio	28.32x
Sector forward P/E	19.93x
Sector P/E	34.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.27%
EBITDA margin	13.42%
Effective tax rate	23.19%
FCF margin	11.73%
Gross margin	47.79%
Operating margin	9.27%
Pretax margin	7.2%
Profit margin	5.53%
Profit per employee	CHF 26,098
Profitable quarters	3
Profitable years	6
Revenue per employee	CHF 471,710
ROA	3.05%
ROA (5Y)	3.17%
ROCE	7.49%
ROE	7.25%
ROE (5Y)	6.57%
ROIC	6.43%
ROIC (5Y)	5.55%
SBC / revenue	1.39%
Tax / revenue	1.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	180.85%
EPS growth (Q)	-71.26%
EPS growth (QoQ)	-79.49%
EPS growth 3Y	0.99%
EPS growth years	0
FCF growth	172.84%
FCF growth (Q)	89.06%
FCF growth (QoQ)	-22.54%
FCF growth 3Y	28.19%
Gross profit growth	10.98%
Gross profit growth (Q)	11.32%
Gross profit growth 3Y	7.2%
Net income growth	184.58%
Net income growth (Q)	-71.09%
Net income growth (QoQ)	-79.7%
Net income growth 3Y	1.76%
Net income growth years	1
OCF growth	104.42%
OCF growth (Q)	66.54%
OCF growth (QoQ)	-18.67%
OCF growth 3Y	26.21%
Operating income growth	72.57%
Operating income growth (Q)	-54.5%
Operating income growth 3Y	2.63%
Revenue growth	10.29%
Revenue growth (Q)	9.86%
Revenue growth (QoQ)	-1.83%
Revenue growth 3Y	6.89%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -449.2M
Depreciation and amortization	CHF 396.6M
EBIT	CHF 874.3M
EBITDA	CHF 1.3B
EPS	CHF 1.19
FCF per share	CHF 2.59
Financing cash flow	CHF 119.6M
Free cash flow	CHF 1.1B
Free cash flow minus SBC	CHF 989M
Gross profit	CHF 4.5B
Income taxes	CHF 157.6M
Investing cash flow	CHF -1.8B
Net borrowing	CHF 484.1M
Net cash flow	CHF -112.3M
Net income	CHF 522M
Operating cash flow minus SBC	CHF 1.4B
Operating income	CHF 874.3M
Revenue	CHF 9.4B
Stock-based compensation	CHF 130.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.56
Book value per share	CHF 16.72
Debt / EBITDA	3.76
Debt / equity	0.69
Debt / FCF	4.48
Goodwill	CHF 6.5B
Interest coverage	4.99
Long-term assets	CHF 11.2B
Long-term liabilities	CHF 4.3B
Net cash (debt)	CHF -3.2B
Net cash / market cap	-8.86%
Net debt / EBITDA	2.51
Net debt / equity	0.44
Net debt / FCF	2.84
Piotroski F-Score	7
Property, plant and equipment	CHF 2.3B
Shareholders' equity	CHF 7.3B
Tangible book value	CHF -632.7M
Tangible book value per share	CHF -1.45
Total assets	CHF 18.4B
Total cash	CHF 1.8B
Total debt	CHF 5B
Total liabilities	CHF 11.1B
WACC	6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	CHF 7.2B
Current liabilities	CHF 6.8B
Current ratio	1.05
Inventory turnover	2.08
Net working capital	CHF -300.6M
Quick ratio	0.62
Working capital	CHF 361.2M
Working capital turnover	8.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.53%
Dividend growth	33.33%
Dividend growth years	1
Dividend payment date	2026-04-15
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	CHF 0.80
Dividend yield	0.97%
Ex-dividend date	2026-04-13
FCF payout ratio	30.91%
Last dividend	CHF 0.80
Payout ratio	68.89%
Shareholder yield	0.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CHF 68.95
1D price change	-0.31%
1M price change	20.49%
1M total return	20.49%
1W price change	0.56%
1W total return	0.56%
1Y price change	54.32%
1Y return CAGR	56.24%
1Y total return	56.19%
20-day SMA	CHF 77.30
200-day SMA	CHF 67.59
3M price change	25.55%
3M total return	25.55%
3Y price change	230.7%
3Y return CAGR	51.23%
3Y total return	245.93%
50-day SMA	CHF 72.35
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 85.62
52-week high date	2026-10-29
52-week low	CHF 52.52
52-week low date	2025-11-07
6M price change	32.01%
6M total return	32.01%
All-time high	CHF 85.62
All-time high date	2026-10-29
All-time low	CHF 22.70
All-time low date	2023-10-04
Average true range (ATR)	CHF 2.42
Average volume	1.2M
Beta (1Y)	1.13
Beta (2Y)	0.95
Beta (5Y)	0.4
Change from 52-week high	-3.53%
Change from 52-week low	57.27%
Change from all-time high	-3.57%
Change from all-time low	263.7%
Change from open	0.27%
Day's gap	-0.58%
Dollar volume	CHF 21.5M
High price	CHF 82.76
Low price	CHF 81.78
Monthly RSI	75.06
Open price	CHF 82.38
Position in 52-week range	83.67%
Previous close	CHF 82.86
Price vs 150-day SMA	19.74%
Price vs 20-day SMA	6.8%
Price vs 200-day SMA	22.15%
Price vs 50-day SMA	14.12%
Relative volume	0.23
RSI	68.85
Sharpe ratio	1.55
Sharpe ratio (3Y)	1.38
Sortino ratio	2.8
Sortino ratio (3Y)	2.37
Volume	260K
Weekly RSI	69.44
YTD price change	42.74%
YTD total return	44.47%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0.14%
Shares change (YoY)	0.53%
Shares held by institutions	36.6%
Shares outstanding	432.7M

Deeper analysis on SWX/SDZ

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/SDZ report

Is a complete SWX/SDZ research report available?

No complete published report is available for swx/SDZ (SWX/SDZ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/SDZ (SWX/SDZ)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/SDZ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/SDZ indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/SDZ

Frequently asked questions